West Nile Virus Disease Author: Amy V. Bode, MD, MSPH; James J. Sejvar, MD; Anthony A. Marfin, MD, MPH
Editorial changes - 2009-06-03
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up
Tables
References
Glossary
What's New
Patient Information
Additional Resources
Tools
Frequently Asked Questions
Prevention
What can be done to prevent outbreaks of WNV?
Is there a vaccine against WNV encephalitis?
Where can I get information about the use of pesticide sprays that are being used for mosquito control?
Screening
What is being done currently to reduce the risk of transfusion-related WNV transmission?
Should people avoid getting blood transfusions or organ transplants?
How can blood banks avoid collecting blood from donors who may have WNV?
Diagnosis
Is WNV seasonal in its occurrence?
What proportion of people with severe illness due to WNV die?
What are WNV meningitis, WNV encephalitis, and WNV acute flaccid paralysis?
Consultation for Diagnosis
Should a neurologic specialist or subspecialist be consulted for diagnosis?
Should an infectious disease specialist or subspecialist be consulted for diagnosis?
Hospitalization
Should patients with encephalitis be hospitalized?
Should patients with acute flaccid paralysis be hospitalized?
Should patients with acute flaccid paralysis be sent for physical rehabilitation?
Non-drug Therapy
Do patients with WNV encephalitis or other neuroinvasive syndromes need intravenous therapy?
Do patients with WNV encephalitis or other neuroinvasive syndromes need ventilatory support?
Do patients with WNV encephalitis or other neuroinvasive syndromes need rehabilitation?
Drug Therapy
Is ribavirin indicated for treatment of WNV meningitis, encephalitis, or other neuroinvasive syndromes?
Is acyclovir indicated for treatment of WNV meningitis, encephalitis, or other neuroinvasive syndromes?
Are corticosteroids indicated for treatment of WNV meningitis, encephalitis, or other neuroinvasive syndromes?
Patient Education
Do patients with muscle weakness often require rehabilitation?
Consultation for Management
Should a neurologic specialist or subspecialist be consulted for management?
Should an infectious disease specialist or subspecialist be consulted for management?
Should a critical care specialist or subspecialist be consulted for management?
Should a physiatrist or subspecialist be consulted for management?
Follow-up
What have been the residua of WNV encephalitis?
What have been the residua of WNV acute flaccid paralysis?
| Patient Information
Amy V. Bode, MD, MSPH has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Anthony A. Marfin, MD, MPH has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. James J. Sejvar, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Yanlin Tang, PhD, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.

The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.